Genes Upcoming Events Announce Your Event Here

11 September 2017 Joint Meeting of IUFRO's WP 7.03.05 & WP 7.03.10 Forest Insects and Pathogens in a Changing Environment: Ecology, Monitoring & Genetics

Thessaloniki, Greece

THE MEETING
The Joint Meeting of IUFRO WP 7.03.05 and 7.03.10 brings together experts from different countries all sharing the same enthusiasm in Forest Entomology and Pathology thus advancing our science and Forest Protection. During this meeting, new and challenging ideas are being exchanged and fruitful discussions are taking place.

TOPICS
At the Joint Meeting of IUFRO WP 7.03.05 and 7.03.10 experts are presenting their up-to-date studies on a good number of topics, among which:
• Ecology and population dynamics of forest insects and pathogens
• Invasive forest pests
• Monitoring, surveillance methodology and management of forest pests
• Chemical ecology of forest insects
• Genetic analysis of forest insects and pathogens

THE PARTICIPANTS
IUFRO meetings are the main scientific events in the field of Forest Sciences in general. As such, these meetings bring together reputable scientists from all over the world. This Joint Meeting in particular examining forest insects and pathogens attracts scientists that are actively involved in shaping national and international policies regarding forest pests.

www.iufrogreece2017.com

9–10 October 2017 2nd Annual Biomarkers & Precision Medicine USA Congress

San Diego, USA

Oxford Global Conferences are proud to present the 2nd Annual Biomarkers & Precision Medicine USA Congress co-located with our 4th Annual Drug Discovery USA Congress, taking place on the 09-10 October 2017 in San Diego, USA.

Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions.

Over 40 presentations, case studies and panel discussions focused on the key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers.

5 Interactive Streams:

  • Biomarkers in Drug Discovery and Development – Translation and Precision Medicine in Auto-Immune Diseases, CNS, Oncology, and Infectious Diseases
  • Personalised Medicine, Companion Diagnostics & Patient Testing
  • Innovations in Biomarker Research – Informatics, Data Management, Assay Development, Imaging Technologies
  • Biomarker in Clinical Development & Clinical Trials
  • Clinical Diagnostics, NGS & Genomic Markers and Genetic Testing

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities. This event is co-located with our 4th Annual Drug Discovery USA Congress.

Free Pre-Congress Webinars

Translational Biomarkers and Companion Diagnostics Development Consortium
22nd June 2017, 9 am. PST, 12 noon EST, 5 pm. BST

Click here to register today, for free.

Scientific and Regulatory Considerations for the Analytical Validation of Assays for the Qualification of Biomarkers

8th August 2017, 9 am. PST, 12 noon EST, 5 pm. BST
Click here to register today, for free.

Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.

For further information, click here: http://bit.ly/22r99ki

http://bit.ly/22r99ki

18–20 October 2017 BioMicroWorld 2017 Conference

Madrid (Spain)

You are cordially invited to participate in the VII International Conference on Environmental, Industrial and Applied Microbiology - BioMicroWorld2017, which will be held in Madrid (Spain) from 18 to 20 October 2017:

The BioMicroWorld Conference is a well-established forum that has brought together researchers in the applied microbiology field every two years since 2005. This forum is aimed at communicating current research priorities and progress in the fields of industrial microbiology, biotechnology, environmental sciences, food and medical microbiology and other related fields, as well as inspiring collaborations for future research. Have a look at the detailed list of topics proposed for the conference at: http://biomicroworld2017.org/topics/

Important deadlines:

- 31 May: early registration
- 27 June: abstract submission (for oral presentation)
- 20 July: abstract submission (for poster and virtual presentation)
- 5 September: late registration
- 2 November: full paper submission

http://biomicroworld2017.org

6–8 June 2017 CROPS 2017

Huntsville, AL, USA

CROPS 2017 is an international conference hosted by the HudsonAlpha Institute for Biotechnology and The University of Georgia.  This conference brings together leading genomic researchers and plant breeders to explore emerging applications of new genomic technology to crop improvement.

http://www.CROPSconference.org

12–13 June 2017 Oxford Global’s - 18th Annual Drug Discovery Leaders’ Summit

Hotel Palace, Berlin, Germany

This summit brings together over 250 key opinion leaders and senior industry experts in drug discovery, to discuss the latest innovative discovery strategies in different therapeutic areas as well as the most effective enabling technologies and solutions. Our co-located 5th Discovery Chemistry & Drug Design Congress provides an unprecedented opportunity to gain insights from key presenters of the computational chemistry, discovery chemistry and medicinal field. 

 

8 interactive streams: 

  • Drug Discovery Innovation and Strategies, Enabling Technologies
  • Novel Drug Target Discovery for Immuno-Therapy, Autoimmune Diseases and Oncology
  • Successful Phenotypic Drug Discovery: High Content Screening
  • RNAi Screening, Cancer Genomics and Gene Editing for Drug Discovery
  • Discovery Chemistry, Medicinal and Computational Chemistry
  • Medicinal Chemistry and Drug Design: Novel Approaches.

Agenda: http://bit.ly/2dUjWB5

Free Pre-Congress Webinars

Drug Discovery Open Innovation & Outsourcing
Hosted by Patrick Kleyn, Director of Drug Target Innovation, EMD Serono
Register for Free Today

Phenotypic Screening in Drug Discovery- Novel Tools & Applications
Hosted by Paul Andrews, Director of Operations, National Phenotypic Screening Centre (NPSC), School of Life Sciences, University of Dundee
Register for Free Today

Disruptive Technologies & Artificial Intelligence in Drug Discovery
Hosted by Chris Gibson, CEO, Recursion Pharmaceuticals
Register for Free Today

For further information on the congress and the webinars, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call +44 (0) 1865 248 455.

http://bit.ly/2dUjWB5

12–13 June 2017 Microbiome Discovery and Development Congress

Berlin Germany

Oxford Global is proud to present the Microbiome Discovery and Development Congress taking place on 12 – 13 June 2017 in Berlin, Germany. This exciting conference showcases world-class speakers discussing novel strategies in microbiome research, challenges of commercialising the microbiome and latest therapeutic trends.

Including 3 Interactive Streams:

  • Microbiome Discovery: Novel Strategies and Technologies
  • Commercialising the Microbiome
  • Therapeutic Potential of the Microbiome

 

View the Agenda: http://bit.ly/2hC8ICR

Free Live Webinar:
Antibiotics & the Microbiome: Protection of the Gut Microbiome from Antibiotics
Hosted by Jean de Gunzburg, CSO, Da Volterra
Register for Free Today: http://bit.ly/2gI1USa

http://bit.ly/2hC8ICR

19–21 June 2017 2017 IMB Conference: Gene Regulation by the Numbers: Quantitative Approaches to Study Transcription

Institute of Molecular Biology (IMB), Mainz, Germany

Key words: Molecular biology, genetics, epigenetics, DNA, RNA, gene regulation, bioinformatics, computational biology, transcription

Keynote speakers:

  • Eileen Furlong, European Molecular Biology Institute (EMBL), Heidelberg, Germany
  • Amos Tanay, The Weizmann Institute, Rehovot, Israel  

Summary of our conference

The focus of the 2017 IMB Conference is on “Gene Regulation by the Numbers: Quantitative Approaches to Study Transcription”. Our conference will explore the latest findings and technological developments in the field of gene regulation. The regulation of gene expression is a highly complex process in which numerous different factors play a role, such as signalling pathways, transcription factors and epigenetic modifications. With the recent surge in the development of omics technologies, researchers have generated vast amounts of data describing the contribution of these factors to controlling gene activity. However, interpreting, validating and integrating the data remains a major challenge. A combination of quantitative analysis and experimental research is therefore crucial to draw a complete picture of gene regulation.

The conference will address major open questions in the field that quantitative approaches will help to address, for example:

  • How do gene regulatory networks make robust decisions in the face of intracellular and environmental fluctuations?
  • How do epigenetic mechanisms ensure that gene expression programmes are faithfully transmitted within cell lineages and from one generation to the next?
  • How do RNA-RNA and RNA-protein interactions control gene expression at the post-transcriptional level?
  • How do DNA sequence variations influence gene expression and phenotypic outcomes, and what are the long-term consequences of this on an evolutionary time scale?
  • How can dynamic models help us to understand signalling, gene regulation and cell fate decision making?
  • Can we improve the speed and accuracy of existing data analysis strategies?
  • What are the upcoming challenges in data analysis?

This conference will be a unique opportunity for participants to learn about the latest discoveries, talk about their own findings and initiate research partnerships. As well as scientific sessions, there will be many networking opportunities, including poster sessions, a conference dinner and an excursion to nearby Kloster Eberbach monastery. We hope that the ideas and concepts developed during the conference will result in exciting collaborations. Anyone interested is welcome to attend and can register online.

www.imb.de/2017conference

9–10 October 2017 4th Annual Drug Discovery USA Congress

San Diego, USA

Oxford Global’s 4th Annual Drug Discovery USA Congress will take place on 9 – 10 October 2017 in San Diego, USA, bringing together over 250 key opinion leaders in drug discovery. This exciting conference showcases the latest technologies and approaches being utilised across Immuno-therapy, Autoimmune diseases, Neuroscience and Oncology. Further sessions consider the key updates in medicinal and computational chemistry. The two-day congress offers an interactive platform for high level discussions, ensuring valuable networking and interactive sessions.

View Agenda: http://bit.ly/1Li0Wd4

4 Interactive Streams:

  • Drug Discovery Innovation and Strategies, Enabling Technologies for Immuno-therapy, Autoimmune Diseases, Neuroscience & Oncology
  • Successful Phenotypic Drug Discovery: High Content Screening
  • Discovery Chemistry: Medicinal and Computational Chemistry
  • Discovery Chemistry: Medicinal Chemistry and Novel Approaches to Drug Design

Free Webinar Recording:

Advance in Fragmented-based Drug Discovery
Hosted by Vincent Stoll, Associate Director of Structural Biology, AbbVie
Download for Free: http://bit.ly/2cuVKoT

For further information regarding prices and possible discounts, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call +44 (0)1865 248 455.

http://bit.ly/1Li0Wd4

Journal Contact

MDPI AG
Genes Editorial Office
St. Alban-Anlage 66, 4052 Basel, Switzerland
E-Mail: 
Tel. +41 61 683 77 34
Fax: +41 61 302 89 18
Editorial Board
Contact Details Submit to Genes Edit a special issue Review for Genes
loading...
Back to Top